Standout Papers

BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo... 2007 2026 2013 2019 683
  1. BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo (2007)
    Martin Steegmaier, Matthias Hoffmann et al. Current Biology

Immediate Impact

3 by Nobel laureates 8 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
2 intermediate papers

Works of Simone Lieb being referenced

Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells
2019
BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
2007 Standout

Author Peers

Author Last Decade Papers Cites
Simone Lieb 711 445 63 317 7 966
Patrick Leroy 566 615 51 416 12 965
Ulrich Gürtler 567 470 34 294 10 771
Kaori Sasai 694 721 58 550 17 1.0k
Anita Diu‐Hercend 710 578 30 440 10 1.1k
Christian Haslinger 753 230 111 304 14 1.0k
Lance Liotta 441 226 47 250 13 779
Alasdair C. Stamps 689 315 34 289 16 1.0k
Monideepa Roy 768 201 57 244 16 1.0k
Angela Pepe 567 459 60 309 6 1.1k
Shlomo Oved 758 301 19 341 6 970

All Works

Loading papers...

Rankless by CCL
2026